NFkB-mediated collagen regulation by SAMe in HSCs

HSC 中 SAMe 介导的 NFkB 介导的胶原蛋白调节

基本信息

  • 批准号:
    7340559
  • 负责人:
  • 金额:
    $ 13.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-02-01 至 2010-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Hepatic fibrosis is characterized by an increase in type I collagen deposition which alters the normal architecture of the liver leading to liver dysfunction. Many etiologies have been associated with hepatic fibrosis with chronic alcohol consumption being the leading cause of liver fibrosis in the United States. The hepatic stellate cell (HSC) is the primary cell type in the liver responsible for excess synthesis of collagen during fibrosis. Following exposure to alcohol, the HSC undergoes a transformation from a quiescent, vitamin A storing cell to that of an activated, collagen producing myofibroblast-like cell. The effects of alcohol on the activation of HSCs have been implicated to alcohol-induced oxidative stress. The metabolism of ethanol leads to the production of free radicals that have been linked to the development of alcohol-induced liver injury. Thus, diminishing oxidative damage by the use of antioxidants may serve as successful therapeutic treatments for liver diseases caused by numerous agents including alcohol. S-adenosyI-L-methionine (SAMe), the precursor of glutathione, has potential usefulness as an antioxidant. SAMe has been shown to improve hepatic fibrosis; however, the molecular mechanisms of SAMe in liver fibrosis is not understood. The role of SAMe as an antioxidant implicates the redox-sensitive transcription factor nuclear factor kappa B (NFkB) and the pathway(s) that regulates its activity as being a key player which may mediate the antioxidant effects of SAMe. SAMe's attenuation of liver fibrosis may occur through the regulation of certain transcription factors that modulate collagen expression in the HSC. Thus, this proposal hypothesizes that the antioxidant SAMe inhibits alcohol-induced collagen expression by modulating NFkB activity in the HSC. The results of these studies will aid in the development of novel therapeutics aimed at preventing the progression of oxidative-induced hepatic fibrosis.
描述(由申请方提供):肝纤维化的特征是I型胶原沉积增加,这改变了肝脏的正常结构,导致肝功能障碍。许多病因与肝纤维化有关,在美国,慢性饮酒是肝纤维化的主要原因。肝星状细胞(HSC)是肝脏中负责纤维化期间胶原蛋白过量合成的主要细胞类型。在暴露于酒精后,HSC经历从静止的、储存维生素A的细胞到活化的、产生胶原蛋白的成肌纤维细胞样细胞的转化。酒精对HSC活化的影响与酒精诱导的氧化应激有关。乙醇的代谢导致自由基的产生,自由基与酒精诱导的肝损伤的发展有关。因此,通过使用抗氧化剂来减少氧化损伤可以作为由包括酒精在内的许多药剂引起的肝脏疾病的成功治疗性治疗。S-腺苷-L-甲硫氨酸(SAMe)是谷胱甘肽的前体,具有潜在的抗氧化作用。SAMe已被证明可以改善肝纤维化;然而,SAMe在肝纤维化中的分子机制尚不清楚。SAMe作为抗氧化剂的作用涉及氧化还原敏感性转录因子核因子κ B(NF κ B)和调节其活性的途径,其是可能介导SAMe的抗氧化作用的关键参与者。SAMe对肝纤维化的减弱可能通过调节HSC中调节胶原蛋白表达的某些转录因子而发生。因此,该提议假设抗氧化剂SAMe通过调节HSC中的NFkB活性来抑制酒精诱导的胶原蛋白表达。这些研究的结果将有助于开发新的治疗方法,旨在防止氧化诱导的肝纤维化的进展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAURA W SCHRUM其他文献

LAURA W SCHRUM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAURA W SCHRUM', 18)}}的其他基金

Role of Exosomal microRNAs in Alcohol-induced Liver Injury
外泌体 microRNA 在酒精性肝损伤中的作用
  • 批准号:
    9382267
  • 财政年份:
    2018
  • 资助金额:
    $ 13.67万
  • 项目类别:
Role of microRNAs in HSC-mediated fibrogenesis
microRNA 在 HSC 介导的纤维发生中的作用
  • 批准号:
    9001886
  • 财政年份:
    2015
  • 资助金额:
    $ 13.67万
  • 项目类别:
NFkB-mediated collagen regulation by SAMe in HSCs
HSC 中 SAMe 介导的 NFkB 介导的胶原蛋白调节
  • 批准号:
    6868558
  • 财政年份:
    2005
  • 资助金额:
    $ 13.67万
  • 项目类别:
NFkB-mediated collagen regulation by SAMe in HSCs
HSC 中 SAMe 介导的 NFkB 介导的胶原蛋白调节
  • 批准号:
    7009644
  • 财政年份:
    2005
  • 资助金额:
    $ 13.67万
  • 项目类别:
NFkB-mediated collagen regulation by SAMe in HSCs
HSC 中 SAMe 介导的 NFkB 介导的胶原蛋白调节
  • 批准号:
    7171537
  • 财政年份:
    2005
  • 资助金额:
    $ 13.67万
  • 项目类别:
Molecular mechanisms of SAMe in hepatic stellate cells
SAMe在肝星状细胞中的分子机制
  • 批准号:
    6593558
  • 财政年份:
    2002
  • 资助金额:
    $ 13.67万
  • 项目类别:
Molecular mechanisms of SAMe in hepatic stellate cells
SAMe在肝星状细胞中的分子机制
  • 批准号:
    6663806
  • 财政年份:
    2002
  • 资助金额:
    $ 13.67万
  • 项目类别:
CFTR PURIFICATION AND DELIVERY TO EPITHELIAL CELLS
CFTR 纯化并输送至上皮细胞
  • 批准号:
    2136037
  • 财政年份:
    1996
  • 资助金额:
    $ 13.67万
  • 项目类别:
CFTR PURIFICATION AND DELIVERY TO EPITHELIAL CELLS
CFTR 纯化并输送至上皮细胞
  • 批准号:
    2136036
  • 财政年份:
    1995
  • 资助金额:
    $ 13.67万
  • 项目类别:
CFTR PURIFICATION AND DELIVERY TO EPITHELIAL CELLS
CFTR 纯化并输送至上皮细胞
  • 批准号:
    2136035
  • 财政年份:
    1994
  • 资助金额:
    $ 13.67万
  • 项目类别:

相似海外基金

Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
  • 批准号:
    10019450
  • 财政年份:
    2019
  • 资助金额:
    $ 13.67万
  • 项目类别:
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
  • 批准号:
    9896234
  • 财政年份:
    2019
  • 资助金额:
    $ 13.67万
  • 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
  • 批准号:
    7990196
  • 财政年份:
    2010
  • 资助金额:
    $ 13.67万
  • 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
  • 批准号:
    8299173
  • 财政年份:
    2010
  • 资助金额:
    $ 13.67万
  • 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
  • 批准号:
    8102173
  • 财政年份:
    2010
  • 资助金额:
    $ 13.67万
  • 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
  • 批准号:
    8494464
  • 财政年份:
    2010
  • 资助金额:
    $ 13.67万
  • 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
  • 批准号:
    8693870
  • 财政年份:
    2010
  • 资助金额:
    $ 13.67万
  • 项目类别:
Screening of food components for the prevention of alcoholic liver diseases and their application
预防酒精性肝病的食品成分筛选及其应用
  • 批准号:
    21500783
  • 财政年份:
    2009
  • 资助金额:
    $ 13.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Contribution of transforming growth factor-a to thr development of hepatic fibrosis in alcoholic liver diseases
转化生长因子-a对酒精性肝病肝纤维化发展的贡献
  • 批准号:
    09670560
  • 财政年份:
    1997
  • 资助金额:
    $ 13.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immunological mechanism on the generation of alcoholic liver diseases
酒精性肝病发生的免疫学机制
  • 批准号:
    03670349
  • 财政年份:
    1991
  • 资助金额:
    $ 13.67万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了